4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-25-002225
President and CEO bought 45,000 shares at $5.69 ($256,050)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Luly Jay R. President and CEO | 2025-02-12 | Purchase | +45,000 | $5.69 | $256,050 | 846,638 | D: show line 1 in the form |
| Open-market purchases · 45,000 sh · avg $5.69 · $256,050 | |||||||
Loading xslF345X05/form4.xml…